See What HealthDay Can Do For You
Contact Us

Health Highlights: April 6, 2015

More Retailers Remove Blue Bell Ice Cream From Stores Bill to Ban Ultrathin Models Moves Forward in France

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

More Retailers Remove Blue Bell Ice Cream From Stores

Two more major U.S. retailers have pulled Blue Bell Ice Cream from their stores as a precautionary measure after after some of the ice cream maker's products were linked to three deaths at a Kansas hospital.

Sam's Club and Kroger have joined the Texas-based H-E-B chain in removing Blue Bell's products from their shelves, the Associated Press reported.

On Friday, Texas-based Blue Bell suspended operations at its plant in Broken Arrow, Okla. after products from that plant and another one in Texas were found to be contaminated with listeria.

Blue Bell spokesman Gene Grabowski said Monday that the number of large retailers pulling the company's ice cream has grown, the AP reported.


Bill to Ban Ultrathin Models Moves Forward in France

New rules to ban dangerously thin models have moved forward in France.

The measures that prohibit modeling agencies from hiring very thin models and require clear labeling of retouched photos of models were approved Friday by the National Assembly, the lower house of Parliament, The New York Times reported.

If the new rules are approved by the Senate, it would make France a leader in fighting the fashion world's use of ultrathin models.

"A person should not be obliged to starve herself in order to work," said Dr. Olivier Vran, the legislator and neurologist who championed the bills, The Times reported.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.